HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marta Di Martile Selected Research

RNA (Ribonucleic Acid)

1/2023Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marta Di Martile Research Topics

Disease

20Neoplasms (Cancer)
05/2024 - 11/2013
17Melanoma (Melanoma, Malignant)
05/2024 - 11/2013
3Lung Neoplasms (Lung Cancer)
06/2020 - 10/2014
2Hematologic Neoplasms (Hematological Malignancy)
01/2023 - 01/2022
2Carcinogenesis
05/2021 - 01/2016
2Hypoxia (Hypoxemia)
04/2021 - 11/2013
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2016 - 10/2014
1Leukemia
01/2023
1Brain Neoplasms (Brain Tumor)
01/2023
1Glioblastoma (Glioblastoma Multiforme)
01/2023
1Ovarian Neoplasms (Ovarian Cancer)
01/2023
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2023
1Sarcoma (Soft Tissue Sarcoma)
02/2018
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2018
1Adenocarcinoma
10/2014
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2014

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
07/2023 - 11/2013
4MicroRNAs (MicroRNA)IBA
11/2023 - 12/2016
3Apoptosis Regulatory ProteinsIBA
07/2023 - 01/2022
3Transcription Factors (Transcription Factor)IBA
04/2021 - 01/2018
3Histone Acetyltransferases (Histone Acetyltransferase)IBA
06/2020 - 03/2016
2Small Interfering RNA (siRNA)IBA
05/2024 - 12/2017
2Biomarkers (Surrogate Marker)IBA
11/2023 - 01/2016
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2023 - 04/2022
2CytokinesIBA
07/2023 - 01/2020
2venetoclaxIBA
01/2023 - 01/2022
2Antineoplastic Agents (Antineoplastics)IBA
01/2023 - 05/2021
2Volatile Oils (Essential Oils)IBA
05/2021 - 09/2020
2Semaphorins (Semaphorin)IBA
04/2021 - 11/2018
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2020 - 11/2013
2EnzymesIBA
06/2020 - 01/2016
2Conditioned Culture MediaIBA
06/2020 - 11/2013
2Lysine AcetyltransferasesIBA
06/2020 - 01/2016
2givinostat hydrochlorideIBA
02/2018 - 10/2014
2Histone Deacetylase InhibitorsIBA
02/2018 - 10/2014
2Histones (Histone)IBA
01/2018 - 01/2016
1NestinIBA
11/2023
1Interleukin-8 (Interleukin 8)IBA
07/2023
1bcl-X ProteinIBA
07/2023
1Chemokine CCL5IBA
07/2023
1ChemokinesIBA
07/2023
1NF-kappa B (NF-kB)IBA
07/2023
1Neutralizing AntibodiesIBA
07/2023
1PhytochemicalsIBA
01/2023
1Immunomodulating AgentsIBA
01/2023
1Lipid NanoparticlesIBA
01/2023
1RNA (Ribonucleic Acid)IBA
01/2023
1Tyrosine (L-Tyrosine)FDA Link
01/2023
1src-Family KinasesIBA
01/2023
1Caspase 8 (Caspase-8)IBA
01/2023
1Indicators and Reagents (Reagents)IBA
04/2022
1Matrix Metalloproteinases (MMPs)IBA
01/2022
1Tea Tree OilIBA
05/2021
1terpinenol-4IBA
05/2021
1trametinibIBA
05/2021
1dabrafenibIBA
05/2021
1Oxygen (Dioxygen)IBA
04/2021
1Glycoproteins (Glycoprotein)IBA
04/2021
1NeuropilinsIBA
04/2021
1TubulinIBA
06/2020
1Angiogenesis InhibitorsIBA
06/2020
1Chemotactic FactorsIBA
01/2020
1Culture MediaIBA
01/2020
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2020
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2020
1Messenger RNA (mRNA)IBA
11/2018
1Proto-Oncogene Proteins c-mybIBA
11/2018
1ChromatinIBA
11/2018
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2018
1Oncogene Proteins (Oncogene Protein)IBA
01/2018
1AcetyltransferasesIBA
01/2018
1Transient Receptor Potential ChannelsIBA
12/2016
1HydrazonesIBA
03/2016
1ThiazolesIBA
03/2016
1Lysine (L-Lysine)FDA Link
01/2016
1Histone Deacetylases (Histone Deacetylase)IBA
10/2014
1Folic Acid (Vitamin M)FDA LinkGeneric
10/2014
1Pemetrexed (MTA)FDA Link
10/2014
1Hypoxia-Inducible Factor 1IBA
11/2013

Therapy/Procedure

17Therapeutics
05/2024 - 01/2016
1Drug Therapy (Chemotherapy)
01/2023
1Aftercare (After-Treatment)
01/2022
1Complementary Therapies (Alternative Medicine)
09/2020